Last reviewed · How we verify

NCT05704777: EYE-FIT

Exercise Intervention in Primary Open-angle Glaucoma

Status unknown NA Last updated 30 January 2023
What this trial tests

NA trial testing Exercise in Glaucoma, Open-Angle in 136 participants. Status unknown.

Timeline
1 February 2023
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorUniversidad de Granada
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment136
Start date1 February 2023
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Granada — full company profile →

Who can join

Adults 50 to 70, any sex, with Glaucoma, Open-Angle or Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

EYE-FIT is a randomized clinical trial with a two-arm parallel design aimed at assessing the impact of performing a structured and supervised physical training program on the different variables associated with glaucoma progression in pharmacologically treated primary open angle glaucoma patients. This intervention will include a supervised 24-weeks concurrent (endurance + resistance) training program comparing its influence to the standard care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Glaucoma, Open-Angle

Currently open trials in the same condition.

Other Universidad de Granada trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05704777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing